|
Dr. S.G.A. Rao
Dr. S. G. A. Rao is a pioneer in stem cell research with more
than three decades of experience in this field. With over 60
research publications in international and national peer
reviewed journals, his seminal work in stem cell research has
been instrumental in bringing stem cell therapy research and
treatment to the fore-front in India. His lab was instrumental
in conducting the first bone marrow transplant in India.
As the former Head of Department of Chemotherapy and Stem Cell
Biology, Cancer Research Institute, Tata Memorial Centre,
Mumbai, India, he brings a wealth of experience to this field.
Dr. Rao was directly responsible for establishing India's first
cord blood stem cell bank, approved by the Drug Controller of
India.
In 2003, he started International Stem cell Services with the
aim of providing a cost-effective option for parents who wanted
to bank their child's umbilical cord stem cells. From the
beginning, International Stem cell Services has also been
working intensively with clinicians to increase the therapeutic
utility of adult stem cells and cord blood stem cell therapy.
This ongoing work has resulted in the worlds
second-largest clinical trial for treatment of peripheral
vascular occlusion (Buergers Disease), which had over 98%
success rate.
Dr. Jyothsna A Rao
Dr. Jyothsna Rao has more than 15 years research experience in
the field of immunology and stem cell Biology. After obtaining
her M. S in Immunology from University of Arkansas, Little Rock,
USA, Dr. Rao worked as a Research Associate in the esteemed
Weill Cornell Medical College in New York City and then at the
world-renowned Rockefeller University. Here she worked on a
developing a path-breaking technique of using dendritic cells
for treatment of cancer. Subsequently, she returned to India
where she obtained a Ph. D, studying signaling pathways in cell
death, from the highly acclaimed National Center for Biological
Sciences, Bangalore and SASTRA University, Tanjavore. Dr. Rao
has numerous peer-reviewed publications in national and
international journals and has presented her work at a number of
international conferences. As part of the International Stem
cell Services team, she contributes her invaluable experience
and knowledge to the development of new clinical protocols for
treatment of incurable diseases such as cancer. She is also
keenly interested in studying the intricacies of stem cell
differentiation and expansion. |